Partial Purification and Pharmacology of Peripheral-Type Benzodiazepine Receptors

References

• Braestrup C., Squires R. F. Specific benzodiazepine receptors in rat brain characterized by high affinity [3H]-diazepam binding. Proc. Natl Acad. Sci. USA 1977; 74: 3805–3809
   PubMed Web of Science ®Google Scholar
• Davies L. P., Huston V. Peripheral benzodiazepine binding sites in heart and their interaction with dipyridamole. Eur. J. Pharmacol. 1981; 73: 209–211
   PubMed Web of Science ®Google Scholar
• Benavides J., Malgouris C., Imbault F., Begassat F., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. “Peripheral-type” benzodiazepine binding sites in rat adrenals: binding studies with [3H] PK 11195 and autoradiographic localization. Arch. Int. Pharmacodyn. 1983; 266: 38–49
   PubMedGoogle Scholar
• Schoemacher H., Bliss M., Yamamura H. I. Specific high-affinity saturable binding of [3H] RO5–4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur. J. Pharmacol. 1981; 71: 173–175
   PubMed Web of Science ®Google Scholar
• Le Fur G., Perrier M. L., Vaucher N., Imbault F., Flamier A., Benavides J., Uzan A., Renault C., Dubroeucq M. C., Gueremy C. Peripheral benzodiazepine binding sites: effects of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(l-methylpropyl)-3-isoquinoline carboxamide. I. In vitro studies. Life Sci. 1983; 32: 1839–1847
   PubMedGoogle Scholar
• Le Fur G., Vaucher N., Perrier M. L., Flamier A., Benavides J., Renault C., Dubroeucq M. C., Gueremy C., Uzan A. Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5–4864 and [3H]PK 11195, by thermo-dynamic studies. Lice Sci. 1983; 33: 449–457
   PubMed Web of Science ®Google Scholar
• Benavides J., Guilloux F., Allam D. E., Uzan A., Mizoule J., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Opposite effects of an agonist, RO5–4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA2/2J mice. Life Sci. 1984; 34: 2613–2620
   PubMed Web of Science ®Google Scholar
• Mestre M., Carriot T., Belin C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Electrophysio-logical and pharmacological characterization of peripheral benzodiazepine receptors in a guinea-pig heart preparation. Life Sci. 1984; 35: 953–962
   PubMed Web of Science ®Google Scholar
• Weissman B. A., Cott J., Jackson J. A., Bolger G. T., Weber K. H., Horst W. D., Paul S. M., Skolnick P. “Peripheral-type” binding sites for benzodiazepines in brain: relationship to the convulsant actions of R05–4864. J. Neurochem. 1985; 44: 1494–1499
   PubMed Web of Science ®Google Scholar
• Mizoule J., Gauthier A., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Opposite effects of two ligands for peripheral-type benzodiazepine binding sites, PK 11195 and R05–4864, in a conflict situation in the rat. Life Sci. 1985; 36: 1059–1068
   PubMed Web of Science ®Google Scholar
• File S. E., Pellow S. The effects of PK 11195, a ligand for peripheral benzodiazepine binding sites, in animal tests of anxiety and stress. Pharmacol. Biochem. Behav. 1985; 23: 737–741
   PubMed Web of Science ®Google Scholar
• Pellow S., File S. E. Behavioural actions of R05–4864: a peripheral type benzodiazepine. Life Sci. 1984; 35: 229–240
   PubMed Web of Science ®Google Scholar
• Wang J. K.T., Morgan J. I., Spector S. Benzodiazepines that bind at peripheral sites inhibit cell proliferation. Proc. Natl Acad. Sci. USA 1984; 81: 753–756
   PubMed Web of Science ®Google Scholar
• Clarke G. D., Ryan P. J. Tranquillizers can block mitogenesis in 3T3 cells and induce differentiation in Friend cells. Nature 1980; 287: 160–161
   PubMed Web of Science ®Google Scholar
• Dubroeucq M. C., Benavides J., Doble A., Guilloux F., Allam D. E., Vaucher N., Bertrand P., Gueremy C., Renault C., Uzan A., Le Fur G. Stereoselective inhibition of the binding of [3H] PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative. Eur. J. Pharmacol.
   Web of Science ®Google Scholar
• Mohler H. Structure and function of the GABA/benzodiazepine receptors. 1986, this volume
   Google Scholar
• Paul S. M., Kempner E. S., Skolnick P. In situ molecular weight determination of brain and peripheral benzodiazepine binding sites. Eur. J. Pharmacol. 1981; 76: 465–166
   PubMed Web of Science ®Google Scholar
• Doble A., Benavides J., Ferris O., Bertrand P., Menager J., Vaucher N., Burgevin M. C., Uzan A., Gueremy C., Le Fur G. Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination. Eur. J. Pharmacol. 1985; 119: 153–167
   PubMed Web of Science ®Google Scholar
• Martini C., Giannaccini G., Lucacchini A. Solubilization of rat kidney benzodiazepine binding sites. Biophys. Biochim. Acta 1983; 728: 289–292
   PubMedGoogle Scholar
• Benavides J., Menager J., Burgevin M. C., Ferris O., Uzan A., Gueremy C., Renault C., Le Fur G. Characterization of solubilized “peripheral type” benzodiazepine binding sites from rat adrenal glands by using [3H]PK 11195, an isoquino-line carboxamide derivative. Biochem. Pharmacol. 1984; 34: 167–170
   Web of Science ®Google Scholar
• Doble A., Ferris O., Burgevin M. C., Menager J., Uzan A., Dubroeucq M. C., Renault C, Gueremy C., Le Fur G. Photoaffinity labelling of peripheral-type benzodiazepine binding sites. Mol. Pharmacol.
   Google Scholar
• Benavides J., Begassat F., Phan T., Tur C., Uzan A., Renault C., Dubroeucq M. C., Gueremy C., Le Fur G. Histidine modification with diethylpyrocarbamate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, R05–4864, of the peripheral benzodiazepine receptors. Life Sci. 1984; 35: 1249–1256
   PubMed Web of Science ®Google Scholar
• Havoundjian H., Cohen R. M., Paul S. M., Skolnick P. Differential sensitivity of “central” and “peripheral” type benzodiazepine receptors to phospholipase A2. J. Neurochem. 1986; 46: 804–811
   PubMed Web of Science ®Google Scholar